Labshake search
Citations for Stemcell Technologies :
101 - 150 of 1019 citations for 6 Bromo 2 trifluoromethylimidazo 1 2 a pyridine since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Molecular Biology 2021Quote: ... and human recombinant IL-2 (Stemcell Technologies, Vancouver, Canada). Activated CD4+ T cells were transfected with pVax-CasRx and gRNA plasmids by nucleofection using Lonza 4d nucleofector ...
-
bioRxiv - Cell Biology 2019Quote: ... in 2 ml of SFEM II (Stem Cell Technologies) supplemented with 10 ng ml−1 IL3 ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 2 mg/mL heparin (#07980; STEMCELL Technologies) on 10 μg/mL human plasma fibronectin (#FC010 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Fibroblast Growth Factor-2 (FGF2, StemCell Technologies Cat#78134.1), Vascular Endothelial Growth Factor-A (VEGF-165 ...
-
bioRxiv - Cancer Biology 2020Quote: ... supplemented with 2 µg/ml heparin sulfate (STEMCELL Technologies) or SFM supplemented with 20 ng/ml human recombinant epidermal growth factor (hEGF ...
-
bioRxiv - Cancer Biology 2021Quote: ... and heparin sulfate (2 µg/mL; 07980, STEMCELL Technologies). The plates were kept in a 37°C ...
-
bioRxiv - Developmental Biology 2021Quote: ... 2 mg/ml DNase I (Stem Cell Technologies, 07900)) ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 2 μg/ml heparin (#07980, Stem Cell Technologies). All cells were tested for mycoplasma contamination ...
-
bioRxiv - Immunology 2023Quote: ... 2 million CD8 T cells (Stemcell Technologies, Cambridge, MA) from three donors were cultured for 48 hours in AIM V Medium (ThermoFisher Scientific ...
-
bioRxiv - Bioengineering 2023Quote: ... IMDM with 2% FBS (StemCell Technologies, Vancouver, BC, Canada). This HSC:MSC resuspension was added to 1 mL MethoCult H4034 Otimum (StemCell Technologies ...
-
bioRxiv - Cancer Biology 2022Quote: ... heparin (2 μg/ml, Stem Cell Technologies, cat# 7980), human bFGF (10 ng/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant EGF (2 ng/mL, STEMCELL Technologies, #78006.2), antibiotic-antimycotic (1X ...
-
bioRxiv - Immunology 2023Quote: ... An underlay of 2 ml of lymphoprep (STEMCELL technologies) was added ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% NeuroCult™ SM1 (Stemcell technologies, cat. no. 05711), 1% N-2 Supplement (Thermo Scientific ...
-
bioRxiv - Cancer Biology 2023Quote: ... Whole blood was diluted 1:1 with phosphate-buffered saline (PBS) containing 2% FBS and then layered onto Lymphoprep (STEMCELL Technologies, 07851) in SepMate-50 isolation tubes (STEMCELL Technologies ...
-
bioRxiv - Bioengineering 2023Quote: ... Stages 1 and 2 used basal media comprised of 1:1 mixture RPMI and DMEM F-12 supplemented with BSA and SM1 (Stem Cell Technology) or B27 (ThermoFisher ...
-
bioRxiv - Immunology 2022Quote: Cells were incubated in 2% FCS in PBS with 1 mM EDTA with human Fc block (STEMCELL Technologies) and stained with Aqua LIVE/DEAD Fixable Dead Cell Stain Kit (Invitrogen ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of ImmunoCult Human CD3/CD28/CD2 T Cell Activator and Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA) as per STEMCELL Technologies Inc ...
-
bioRxiv - Developmental Biology 2023Quote: ... differentiating cells were confluent again and split 1:3-1:4 into Step 2 differentiation medium: BrainPhys Neuronal Medium (STEMCELL Technologies, cat# 05790), 1X N2 ...
-
bioRxiv - Developmental Biology 2022Quote: ... Cells were passaged 1:6 using RELESR (StemCell Technologies 05872) for detachment of hESCs ...
-
bioRxiv - Immunology 2021Quote: ... (2) ImmunoCult™-XF T Cell Expansion Medium (STEMCELL Technologies) was supplemented with 1X Penicillin Streptomycin solution (ICM) ...
-
bioRxiv - Microbiology 2023Quote: ... and Heparin solution (2 μl/ml; Stem cell technologies #07980).
-
bioRxiv - Cancer Biology 2023Quote: ... heparin solution (final concentration, 2 µg/mL, STEMCELL Technologies, 07980), recombinant human EGF (20 ng/mL ...
-
bioRxiv - Cell Biology 2023Quote: ... for EB formation in APEL-2 media (Stemcell Technologies, 5275) containing 10µM ROCK inhibitor ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies, Cambridge, MA 02142) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Biophysics 2024Quote: ... ovaries were treated with collagenase (2 mg/mL; StemCell Technologies) and incubated in Modified Bath Saline (MBS ...
-
bioRxiv - Bioengineering 2024Quote: ... and 2 mg/mL dispase II (STEMCELL Technologies, Vancouver, Canada) for 4 hours under gentle agitation at 37° C ...
-
bioRxiv - Molecular Biology 2023Quote: ... T cells were cultured at ∼1-2 x 106mL in ImmunoCult-XF T cell expansion medium (StemCell Technologies, Canada) supplemented with Penicillin-Streptomycin (Gibco ...
-
bioRxiv - Neuroscience 2023Quote: ... and cells were passaged 1-2 times per week using an enzyme-free reagent (ReLeSR; Stem Cell Technologies, 05872). Cells were checked for mycoplasma contamination every two weeks ...
-
bioRxiv - Cell Biology 2023Quote: Mature organoids are collected by rinsing the maintenance well using 1-2 ml cold DMEM/F12 (Stem Cell Technologies) + 15 mM HEPES + 1x GlutaMax (1:100 35050-038 ...
-
bioRxiv - Biophysics 2023Quote: ... and the media further supplemented with 30 U mL-1 of human recombinant IL-2 protein (STEMCELL Technologies, USA). T cells were incubated in a humidified incubator with 5% CO2 at 37°C and were split to 0.5×106 cells mL-1 when their concentration surpassed 2.5×106 cells per well or when medium became depleted (turning yellow in color) ...
-
bioRxiv - Cell Biology 2020Quote: ... the iPSC were maintained in StemFlex medium and passaged 1-2 a week using ReLSR (STEMCELL Technologies, Vancouver, BC, Canada) dissociation buffer ...
-
bioRxiv - Bioengineering 2021Quote: ... All human iPSCs were cultured on Matrigel (Corning)-coated 6-well plates with mTeSR™1 medium (StemCell Technologies). Full-volume medium replacement with mTESR1 was performed daily ...
-
bioRxiv - Cancer Biology 2020Quote: ... Pellet is resuspended in 2-5ml accutase™ (StemCell Technologies, 07920), depending on the sample amount ...
-
bioRxiv - Developmental Biology 2022Quote: ... cells were collected with 2 mL mTeSRplus (Stem Cell Technologies, 05825), span down and resuspended in 1 mL mTeSRplus ...
-
bioRxiv - Cancer Biology 2020Quote: ... Pellet is resuspended in 2-5ml accutase™ (StemCell Technologies, 07920), depending on the sample amount ...
-
bioRxiv - Bioengineering 2021Quote: ... additionally supplemented with cytokines (Human Recombinant IL-2; Stemcell Technologies - #78036). To stimulate the cells ...
-
bioRxiv - Cancer Biology 2022Quote: ... PHA was washed and IL-2 (50 U/ml, StemCell Technology) was added to the medium and replaced every 2 days for a time period of 5 days.
-
A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis BullosabioRxiv - Bioengineering 2023Quote: ... 2% BSA (Miltenyi) and 10 uM ROCK inhibitor (StemCell technologies 72302). For all wash steps ...
-
bioRxiv - Developmental Biology 2022Quote: ... Cultures were passaged 1:6 in 6-well plates every 4-7 days using Gentle Cell Dissociation Reagent (GCDR, STEMCELL Technologies). Cells were cryopreserved in mFreSR.
-
bioRxiv - Bioengineering 2021Quote: ... microcapsules carrying HUES-8 cells were immersed in E8 medium for 1 h immediately after encapsulation and then transferred into E6 medium (without FGF-2 and TGF-β1, STEMCELL Technologies) for subsequent cultivation (2000 microcapsules per well) ...
-
bioRxiv - Cancer Biology 2022Quote: ... Tissues were cut into 1-2 mm pieces and subsequently incubated in serum-free medium containing collagenase/hyaluronidase (Stem Cell Technologies) at 37 ºC ...
-
bioRxiv - Cancer Biology 2023Quote: ... co-cultures were counted and recultured as 1 x 106 cells/ml in fresh medium containing 20 U/ml recombinant human IL-2 (StemCell Technologies) in the presence of soquelitinib or DMSO for additional 5 days ...
-
bioRxiv - Bioengineering 2023Quote: ... The PBMC pellet was resuspended in PBS supplemented with 2% FBS and 1 mM EDTA and monocyte isolation was performed using the EasySepTM human monocyte isolation kit (Stemcell Technologies) according to manufacturer instructions ...
-
bioRxiv - Neuroscience 2024Quote: ... SH-SY5Y cells were counted and seeded at a density of 10.4 × 103 cells/cm2 in differentiation media (Neurobasal medium, 2% B27 supplement, 1% GlutaMAX, and 10 μM of all-trans retinoic acid [STEMCELL Technologies]). Differentiation media was replaced every other day until day 9 post-seeding ...
-
bioRxiv - Immunology 2024Quote: ... were differentiated into TH2 T cell subtype by incubation with specific supplement for TH2 differentiation (mouse IL-2, mouse IL-4 and rat anti mouse IFNγ with 1:100 dilution (STEMCELL Technologies)) and incubated for 3 days on plates coated with aCD3 and aCD28 antibodies ...
-
bioRxiv - Cancer Biology 2022Quote: ... using base medium (1:1 ratio of DMEM/F12 Glutamax/Neurobasal medium [Gibco], 2% B27 supplement without vitamin A [Gibco], 10% BIT 9500 [StemCell Technologies], and 1 mM glutamine [Gibco]) supplemented with 20ng/ml EGF (Chemicon) ...
-
bioRxiv - Molecular Biology 2021Quote: ... 2 million cells were passaged per each well using Accutase (StemCell Technologies) into the STEMdiff SMADi neural induction medium (StemCell Technologies) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 20 ng/ml basic-FGF and 2 μg/ml Heparin (StemCell Technologies). L0125 and L0512 GBM tumorspheres were kindly provided by Dr ...